Lantic Inc.
Acted for Lantic Inc. in its strategic collaboration with DouxMatok to deliver a unique sugar reduction solution on cane sugar to food companies in North America.
Sébastien Roy
Partner
Bar Admissions
- Québec, 2003
Sébastien advises on significant public and private mergers and acquisitions.
He also represents issuers and underwriters in public offerings and private placements of equity and debt securities, in both Canada and the U.S. He works extensively with REITS, financial institutions and financial technology and life science companies. Sébastien has also represented investors with their investments in Canadian mining companies and is a member of the China practice group. Clients regularly turn to him for assistance with securities regulation compliance and corporate governance advice.
Sébastien is a long-standing contributor to Montréal’s vital arts scene, both as a fundraiser and as a volunteer. He is chairman of the board of Fondation de la Maison Théâtre.
Sébastien Roy
Partner
Sébastien advises on significant public and private mergers and acquisitions.
He also represents issuers and underwriters in public offerings and private placements of equity and debt securities, in both Canada and the U.S. He works extensively with REITS, financial institutions and financial technology and life science companies. Sébastien has also represented investors with their investments in Canadian mining companies and is a member of the China practice group. Clients regularly turn to him for assistance with securities regulation compliance and corporate governance advice.
Sébastien is a long-standing contributor to Montréal’s vital arts scene, both as a fundraiser and as a volunteer. He is chairman of the board of Fondation de la Maison Théâtre.
BELLUS Health Inc.
Acted for BELLUS Health Inc. in its US$40-million public offering in the United States.
Cominar Real Estate Investment Trust
Acted for Cominar Real Estate Investment Trust in its private placement of $150 million of 5.95% Series 12 senior unsecured debentures due May 5, 2025.
Bellus Health Inc.
Acted for Bellus Health Inc. in its acquisition of the BLU-5937 and related P2X3 antagonists intellectual property assets from adMare BioInnovations' NEOMED Institute.
BofA Securities, Inc., Barclays, J.P. Morgan and TD Securities
Acted as Canadian counsel to the syndicate of initial purchasers led by BofA Securities, Inc., Barclays, J.P. Morgan and TD Securities in an offering of US$450 million of senior secured notes of Garda World Security Corporation.
Health & Happiness (H&H) Hong Kong Limited
Acted for NewH2 Limited, a subsidiary of Health and Happiness (H&H) International Holdings Limited, in its private placement of C$5.75 million in Else Nutrition Holdings Inc., an Israel-based company, as part of an aggregate private placement offering of up to C$8.0 million.
BMO Nesbitt Burns Inc.
Acted for a syndicate of agents co-led by BMO Nesbitt Burns Inc., National Bank Financial Inc. and RBC Dominion Securities Inc. in connection with the offering by Metro Inc. of $400 million aggregate principal amount of Series I, 3.413% senior unsecured notes due February 28, 2050.
Caisse de dépôt et placement du Québec
Acted for Caisse de dépôt et placement du Québec (Caisse) and CDP Financial Inc. in CDP Financial's establishment and launch of a US$20-billion senior notes program guaranteed by Caisse, including four subsequent offerings by CDP Financial totalling US$8.5 billion in senior notes under the program.
Gelpac Inc. and Namakor Holdings
Acted for Namakor Holdings and its portfolio company Gelpac Inc., a Canadian leader of high-performance packaging solutions, in the strategic acquisition of WBC Extrusion Products, Inc., a U.S. specialty manufacturer of single-use blown polymer films.
BofA Securities, Inc., Barclays, J.P. Morgan and TD Securities
Acted as Canadian counsel to the syndicate of initial purchasers led by BofA Securities, Inc., Barclays, J.P. Morgan and TD Securities in an offering of US$779 million of 9.50% senior notes due 2027 of Garda World Security Corporation and to the solicitation agents in respect of the offer to purchase and consent to solicitation in respect of Garda World's US$625 million 8.75% senior notes due 2025.
Bulletin
Aug. 27, 2019 - The Business Roundtable, an association of CEOs of major U.S. corporations, recently issued its “Statement on the Purpose of the Corporation. ” The statement underscores the Business Roundtable’s commitment to all stakeholders of corporations, including their customers, employees, suppliers,...
In the News
Sébastien Roy Interviewed by Lexpert about Dealmaking in the Maple Syrup Business
Feb. 13, 2018 - Davies partner Sébastien Roy was recently interviewed for a Lexpert Magazine article about transactions in the maple syrup industry, including Rogers Sugar’s (RSI’s) $160.3-million acquisition of L.B. Maple Treat (LBMT) last August. Sébastien believes it was the right time for RSI and...
Guide
Sept. 21, 2015 - The multijurisdictional disclosure system (MJDS) permits eligible Canadian issuers to publicly offer securities in the United States by using a prospectus that is prepared principally in accordance with Canadian disclosure requirements. The MJDS also enables these issuers to substantially satisfy...
Bulletin
Let’s Meet Halfway: CSA Adopts Amendments to Streamline Venture Issuers’ Disclosure
Apr. 15, 2015 - On April 9, 2015, the Canadian Securities Administrators (CSA) announced the adoption of amendments to continuous disclosure, governance and prospectus disclosure requirements (the Amendments). 1 Most of the Amendments streamline the disclosure requirements for venture issuers and aim to reduce...
Bulletin
Women on Boards and in Senior Management: Final Disclosure Rules Released
Oct. 15, 2014 - On October 15, 2014, the securities regulatory authorities of Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Ontario, Québec and Saskatchewan (the participating jurisdictions) announced the final amendments to National Instrument 58-101...
Bulletin
CSA Propose Amendments to Streamline Venture Issuers Disclosure
June 03, 2014 - On May 22, 2014, the Canadian Securities Administrators (the CSA) published for comment proposed amendments to National Instrument 51-102 Continuous Disclosure Obligations (referred to in Québec as Regulation 51-102 respecting Continuous Disclosure Obligations) (collectively, NI...
IFLR1000: The Guide to the World’s Leading Financial Law Firms—Capital Markets: Debt; Capital Markets: Equity
The Canadian Legal Lexpert Directory—Corporate Finance and Securities; Corporate Mid-Market; Mergers and Acquisitions
The Best Lawyers in Canada—Mergers and Acquisitions Law; Securities Law
Bar Admissions
Québec, 2003
Education
Harvard Law School, Executive Education: Accelerated Leadership Program, 2016
McGill University, BCL/LLB (with Great Distinction), 2002
McGill University, BA Philosophy (with Distinction), 1999
Board Memberships
The Canadian Club of Montréal, director
BELLUS Health Inc., corporate secretary
Fondation de la Maison Théâtre, chairman
